The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Female Sexual Dysfunction Treatment Drug Market Research Report 2024
Synopsis
Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The global Female Sexual Dysfunction Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Female Sexual Dysfunction Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Female Sexual Dysfunction Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Female Sexual Dysfunction Treatment Drug include Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, Lupin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Female Sexual Dysfunction Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Sexual Dysfunction Treatment Drug.
The Female Sexual Dysfunction Treatment Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Female Sexual Dysfunction Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Female Sexual Dysfunction Treatment Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Teva Pharmaceuticals
Duchesnay
Sprout Pharmaceuticals
Cosette Pharmaceuticals
Lupin
Segment by Type
Estrogen Therapy
Ospemifene
Flibanserin
Bremelanotide
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Female Sexual Dysfunction Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Female Sexual Dysfunction Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The global Female Sexual Dysfunction Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Female Sexual Dysfunction Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Female Sexual Dysfunction Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Female Sexual Dysfunction Treatment Drug include Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, Lupin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Female Sexual Dysfunction Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Sexual Dysfunction Treatment Drug.
The Female Sexual Dysfunction Treatment Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Female Sexual Dysfunction Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Female Sexual Dysfunction Treatment Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Teva Pharmaceuticals
Duchesnay
Sprout Pharmaceuticals
Cosette Pharmaceuticals
Lupin
Segment by Type
Estrogen Therapy
Ospemifene
Flibanserin
Bremelanotide
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Female Sexual Dysfunction Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Female Sexual Dysfunction Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Female Sexual Dysfunction Treatment Drug Market Overview
1.1 Product Definition
1.2 Female Sexual Dysfunction Treatment Drug by Type
1.2.1 Global Female Sexual Dysfunction Treatment Drug Market Value Comparison by Type (2024-2030)
1.2.2 Estrogen Therapy
1.2.3 Ospemifene
1.2.4 Flibanserin
1.2.5 Bremelanotide
1.2.6 Others
1.3 Female Sexual Dysfunction Treatment Drug by Application
1.3.1 Global Female Sexual Dysfunction Treatment Drug Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Female Sexual Dysfunction Treatment Drug Market Size Estimates and Forecasts
1.4.1 Global Female Sexual Dysfunction Treatment Drug Revenue 2019-2030
1.4.2 Global Female Sexual Dysfunction Treatment Drug Sales 2019-2030
1.4.3 Global Female Sexual Dysfunction Treatment Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Female Sexual Dysfunction Treatment Drug Market Competition by Manufacturers
2.1 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Female Sexual Dysfunction Treatment Drug Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Female Sexual Dysfunction Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Product Type & Application
2.7 Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Date of Enter into This Industry
2.8 Global Female Sexual Dysfunction Treatment Drug Market Competitive Situation and Trends
2.8.1 Global Female Sexual Dysfunction Treatment Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Female Sexual Dysfunction Treatment Drug Players Market Share by Revenue
2.8.3 Global Female Sexual Dysfunction Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Female Sexual Dysfunction Treatment Drug Market Scenario by Region
3.1 Global Female Sexual Dysfunction Treatment Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Female Sexual Dysfunction Treatment Drug Sales by Region: 2019-2030
3.2.1 Global Female Sexual Dysfunction Treatment Drug Sales by Region: 2019-2024
3.2.2 Global Female Sexual Dysfunction Treatment Drug Sales by Region: 2025-2030
3.3 Global Female Sexual Dysfunction Treatment Drug Revenue by Region: 2019-2030
3.3.1 Global Female Sexual Dysfunction Treatment Drug Revenue by Region: 2019-2024
3.3.2 Global Female Sexual Dysfunction Treatment Drug Revenue by Region: 2025-2030
3.4 North America Female Sexual Dysfunction Treatment Drug Market Facts & Figures by Country
3.4.1 North America Female Sexual Dysfunction Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2030)
3.4.3 North America Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Female Sexual Dysfunction Treatment Drug Market Facts & Figures by Country
3.5.1 Europe Female Sexual Dysfunction Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2030)
3.5.3 Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Female Sexual Dysfunction Treatment Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Female Sexual Dysfunction Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2030)
3.6.3 Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Female Sexual Dysfunction Treatment Drug Market Facts & Figures by Country
3.7.1 Latin America Female Sexual Dysfunction Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2030)
3.7.3 Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Female Sexual Dysfunction Treatment Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Female Sexual Dysfunction Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2030)
4.1.1 Global Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
4.1.2 Global Female Sexual Dysfunction Treatment Drug Sales by Type (2025-2030)
4.1.3 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2030)
4.2 Global Female Sexual Dysfunction Treatment Drug Revenue by Type (2019-2030)
4.2.1 Global Female Sexual Dysfunction Treatment Drug Revenue by Type (2019-2024)
4.2.2 Global Female Sexual Dysfunction Treatment Drug Revenue by Type (2025-2030)
4.2.3 Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2030)
4.3 Global Female Sexual Dysfunction Treatment Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2030)
5.1.1 Global Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
5.1.2 Global Female Sexual Dysfunction Treatment Drug Sales by Application (2025-2030)
5.1.3 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2030)
5.2 Global Female Sexual Dysfunction Treatment Drug Revenue by Application (2019-2030)
5.2.1 Global Female Sexual Dysfunction Treatment Drug Revenue by Application (2019-2024)
5.2.2 Global Female Sexual Dysfunction Treatment Drug Revenue by Application (2025-2030)
5.2.3 Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2019-2030)
5.3 Global Female Sexual Dysfunction Treatment Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Female Sexual Dysfunction Treatment Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Female Sexual Dysfunction Treatment Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Duchesnay
6.3.1 Duchesnay Company Information
6.3.2 Duchesnay Description and Business Overview
6.3.3 Duchesnay Female Sexual Dysfunction Treatment Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Duchesnay Female Sexual Dysfunction Treatment Drug Product Portfolio
6.3.5 Duchesnay Recent Developments/Updates
6.4 Sprout Pharmaceuticals
6.4.1 Sprout Pharmaceuticals Company Information
6.4.2 Sprout Pharmaceuticals Description and Business Overview
6.4.3 Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolio
6.4.5 Sprout Pharmaceuticals Recent Developments/Updates
6.5 Cosette Pharmaceuticals
6.5.1 Cosette Pharmaceuticals Company Information
6.5.2 Cosette Pharmaceuticals Description and Business Overview
6.5.3 Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolio
6.5.5 Cosette Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Company Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Female Sexual Dysfunction Treatment Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Female Sexual Dysfunction Treatment Drug Product Portfolio
6.6.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Female Sexual Dysfunction Treatment Drug Industry Chain Analysis
7.2 Female Sexual Dysfunction Treatment Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Female Sexual Dysfunction Treatment Drug Production Mode & Process
7.4 Female Sexual Dysfunction Treatment Drug Sales and Marketing
7.4.1 Female Sexual Dysfunction Treatment Drug Sales Channels
7.4.2 Female Sexual Dysfunction Treatment Drug Distributors
7.5 Female Sexual Dysfunction Treatment Drug Customers
8 Female Sexual Dysfunction Treatment Drug Market Dynamics
8.1 Female Sexual Dysfunction Treatment Drug Industry Trends
8.2 Female Sexual Dysfunction Treatment Drug Market Drivers
8.3 Female Sexual Dysfunction Treatment Drug Market Challenges
8.4 Female Sexual Dysfunction Treatment Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Female Sexual Dysfunction Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Female Sexual Dysfunction Treatment Drug Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Female Sexual Dysfunction Treatment Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Female Sexual Dysfunction Treatment Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Female Sexual Dysfunction Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Female Sexual Dysfunction Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Product Type & Application
Table 12. Global Key Manufacturers of Female Sexual Dysfunction Treatment Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Female Sexual Dysfunction Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Sexual Dysfunction Treatment Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Female Sexual Dysfunction Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2019-2024)
Table 19. Global Female Sexual Dysfunction Treatment Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2025-2030)
Table 21. Global Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Female Sexual Dysfunction Treatment Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Female Sexual Dysfunction Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Table 53. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2025-2030)
Table 54. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Female Sexual Dysfunction Treatment Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Table 63. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2025-2030)
Table 64. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Female Sexual Dysfunction Treatment Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Female Sexual Dysfunction Treatment Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Pharmaceuticals Company Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Duchesnay Company Information
Table 81. Duchesnay Description and Business Overview
Table 82. Duchesnay Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Duchesnay Female Sexual Dysfunction Treatment Drug Product
Table 84. Duchesnay Recent Developments/Updates
Table 85. Sprout Pharmaceuticals Company Information
Table 86. Sprout Pharmaceuticals Description and Business Overview
Table 87. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 89. Sprout Pharmaceuticals Recent Developments/Updates
Table 90. Cosette Pharmaceuticals Company Information
Table 91. Cosette Pharmaceuticals Description and Business Overview
Table 92. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product
Table 94. Cosette Pharmaceuticals Recent Developments/Updates
Table 95. Lupin Company Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lupin Female Sexual Dysfunction Treatment Drug Product
Table 99. Lupin Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Female Sexual Dysfunction Treatment Drug Distributors List
Table 103. Female Sexual Dysfunction Treatment Drug Customers List
Table 104. Female Sexual Dysfunction Treatment Drug Market Trends
Table 105. Female Sexual Dysfunction Treatment Drug Market Drivers
Table 106. Female Sexual Dysfunction Treatment Drug Market Challenges
Table 107. Female Sexual Dysfunction Treatment Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Female Sexual Dysfunction Treatment Drug
Figure 2. Global Female Sexual Dysfunction Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Female Sexual Dysfunction Treatment Drug Market Share by Type: 2023 & 2030
Figure 4. Estrogen Therapy Product Picture
Figure 5. Ospemifene Product Picture
Figure 6. Flibanserin Product Picture
Figure 7. Bremelanotide Product Picture
Figure 8. Others Product Picture
Figure 9. Global Female Sexual Dysfunction Treatment Drug Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Female Sexual Dysfunction Treatment Drug Market Share by Application: 2023 & 2030
Figure 11. Hospital Pharmacies
Figure 12. Private Clinics
Figure 13. Retail Pharmacies
Figure 14. E-Commerce (B2B)
Figure 15. E-Commerce (B2C)
Figure 16. Global Female Sexual Dysfunction Treatment Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Female Sexual Dysfunction Treatment Drug Market Size (2019-2030) & (US$ Million)
Figure 18. Global Female Sexual Dysfunction Treatment Drug Sales (2019-2030) & (K Units)
Figure 19. Global Female Sexual Dysfunction Treatment Drug Average Price (US$/Unit) & (2019-2030)
Figure 20. Female Sexual Dysfunction Treatment Drug Report Years Considered
Figure 21. Female Sexual Dysfunction Treatment Drug Sales Share by Manufacturers in 2023
Figure 22. Global Female Sexual Dysfunction Treatment Drug Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Female Sexual Dysfunction Treatment Drug Players: Market Share by Revenue in Female Sexual Dysfunction Treatment Drug in 2023
Figure 24. Female Sexual Dysfunction Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Female Sexual Dysfunction Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 27. North America Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 28. United States Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 31. Europe Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 32. Germany Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2019-2030)
Figure 39. China Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 47. Mexico Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Female Sexual Dysfunction Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Female Sexual Dysfunction Treatment Drug by Type (2019-2030)
Figure 57. Global Revenue Market Share of Female Sexual Dysfunction Treatment Drug by Type (2019-2030)
Figure 58. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Female Sexual Dysfunction Treatment Drug by Application (2019-2030)
Figure 60. Global Revenue Market Share of Female Sexual Dysfunction Treatment Drug by Application (2019-2030)
Figure 61. Global Female Sexual Dysfunction Treatment Drug Price (US$/Unit) by Application (2019-2030)
Figure 62. Female Sexual Dysfunction Treatment Drug Value Chain
Figure 63. Female Sexual Dysfunction Treatment Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
